Skip to main content
DGX logo

DGX · Quest Diagnostics Inc

$238.50 +2.66 (+1.13%) At close · Aug 6
Market Cap
$26.32B
Shares
110.37M

Quest Diagnostics Inc Earnings Call Transcripts

Every quarterly earnings call for Quest Diagnostics Inc (DGX) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY26 · Q2
2026-07-23
Q2 2026 Quest Diagnostics Earnings Conference Call
Confident tone PAMA, Results Act and reimbursement risk Advanced diagnostics and clinical areas Alzheimer's biomarker reimbursement
Revenue
$3.04B
▲ 10.2% YoY
Diluted EPS
$2.84
▲ 15% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-04-21
Quest Diagnostics Inc Q1 FY2026 Earnings Call
Confident tone Consumer Health and QuestHealth AI and Automation Deployment Organic Revenue Growth
Revenue
$2.90B
▲ 9.2% YoY
Diluted EPS
$2.24
▲ 15.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-10
Quest Diagnostics Inc Q4 FY2025 Earnings Call
Positive tone Weather impact and seasonality PAMA reimbursement delay and structural risk Health plan access and Elevance share gains
Revenue
$2.81B*
▲ 7.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-10-21
Quest Diagnostics Inc Q3 FY2025 Earnings Call
Confident tone Consumer channel momentum Project Nova and QARA investments Acquisitions as growth driver
Revenue
$2.82B
▲ 13.2% YoY
Diluted EPS
$2.16
▲ 8.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-22
Quest Diagnostics Inc Q2 FY2025 Earnings Call
Confident tone Organic revenue growth and utilization Acquisitions as growth driver Raised full-year guidance
Revenue
$2.76B
▲ 15.2% YoY
Diluted EPS
$2.47
▲ 21.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2025-06-03
William Blair 45th Annual Growth Stock Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q1
2025-04-22
Quest Diagnostics Inc Q1 FY2025 Earnings Call
Positive tone Revenue growth and organic performance Guidance reaffirmation and EPS cadence Labor and expense management
Revenue
$2.65B
▲ 12.1% YoY
Diluted EPS
$1.94
▲ 12.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Capital Markets Day
Investor event
2025-03-19
Quest Diagnostics to Host Investor Day on March 19, 2025
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY24 · Q4
2025-01-30
Quest Diagnostics Inc Q4 FY2024 Earnings Call
Confident tone Acquisitions Strategy Revenue Growth and Financial Performance Advanced Diagnostics and Specialty Testing
Revenue
$2.62B*
▲ 14.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-22
Quest Diagnostics Inc Q3 FY2024 Earnings Call
Confident tone Acquisitions and M&A Growth PAMA / Medicare Reimbursement Risk Hospital and Health System Partnerships
Revenue
$2.49B
▲ 8.4% YoY
Diluted EPS
$1.99
▲ 1.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-23
Quest Diagnostics Inc Q2 FY2024 Earnings Call
Confident tone Acquisitions and M&A pipeline Advanced diagnostics growth Operational improvement via automation and AI
Revenue
$2.40B
▲ 2.5% YoY
Diluted EPS
$2.03
▼ 1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-04-23
Quest Diagnostics Inc Q1 FY2024 Earnings Call
Confident tone Advanced Diagnostics portfolio expansion Invigorate initiative / automation and AI productivity Base business revenue growth and momentum
Revenue
$2.37B
▲ 1.5% YoY
Diluted EPS
$1.72
▼ 3.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-01
Quest Diagnostics Inc Q4 FY2023 Earnings Call
Confident tone Base business revenue growth and 2023 results M&A and hospital outreach acquisitions Regulatory and reimbursement environment (PAMA, LDTs, FDA)
Revenue
$2.29B*
▼ 1.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-10-24
Quest Diagnostics Inc Q3 FY2023 Earnings Call
Revenue
$2.29B
▼ 7.7% YoY
Diluted EPS
$1.96
▼ 9.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-07-26
Quest Diagnostics Inc Q2 FY2023 Earnings Call
Revenue
$2.34B
▼ 4.7% YoY
Diluted EPS
$2.05
▲ 4.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-04-27
Quest Diagnostics Inc Q1 FY2023 Earnings Call
Revenue
$2.33B
▼ 10.7% YoY
Diluted EPS
$1.78
▼ 39% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-02
Quest Diagnostics Inc Q4 FY2022 Earnings Call
Revenue
$2.33B*
▼ 15% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-10-20
Quest Diagnostics Inc Q3 FY2022 Earnings Call
Revenue
$2.49B
▼ 10.4% YoY
Diluted EPS
$2.17
▼ 46% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-07-21
Quest Diagnostics Inc Q2 FY2022 Earnings Call
Revenue
$2.45B
▼ 3.8% YoY
Diluted EPS
$1.96
▼ 60.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-04-21
Quest Diagnostics Inc Q1 FY2022 Earnings Call
Revenue
$2.61B
▼ 4% YoY
Diluted EPS
$2.92
▼ 15.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-03
Quest Diagnostics Inc Q4 FY2021 Earnings Call
Revenue
$2.74B*
▼ 8.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-10-21
Quest Diagnostics Inc Q3 FY2021 Earnings Call
Revenue
$2.77B
▼ 0.4% YoY
Diluted EPS
$4.02
▼ 2.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-07-22
Quest Diagnostics Inc Q2 FY2021 Earnings Call
Revenue
$2.55B
▲ 39.6% YoY
Diluted EPS
$4.96
▲ 264.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-04-22
Quest Diagnostics Inc Q1 FY2021 Earnings Call
Revenue
$2.72B
▲ 49.3% YoY
Diluted EPS
$3.46
▲ 374% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-04
Quest Diagnostics Inc Q4 FY2020 Earnings Call
Revenue
$3.00B
▲ 55.9% YoY
Diluted EPS
$4.21
▲ 126.3% YoY
Gross margin
42.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-22
Quest Diagnostics Inc Q3 FY2020 Earnings Call
Revenue
$2.79B
▲ 42.4% YoY
Diluted EPS
$4.14
▲ 165.4% YoY
Gross margin
43.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-23
Quest Diagnostics Inc Q2 FY2020 Earnings Call
Revenue
$1.83B
▼ 6.5% YoY
Diluted EPS
$1.36
▼ 18.1% YoY
Gross margin
33.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-22
Quest Diagnostics Inc Q1 FY2020 Earnings Call
Revenue
$1.82B
▼ 3.6% YoY
Diluted EPS
$0.73
▼ 39.2% YoY
Gross margin
30.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-01-30
Quest Diagnostics Inc Q4 FY2019 Earnings Call
Revenue
$1.93B
▲ 4.7% YoY
Diluted EPS
$1.86
▲ 102.2% YoY
Gross margin
34.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–29 of 29 earnings calls
Key facts CIK 1022079 CUSIP 74834L100 13F (30d) 578 filings 551 filers Visit website Investor relations